DAILY VERSUS ALTERNATE-DAY ROSUVASTATIN FOR DYSLIPIDEMIA: A RANDOMIZED CONTROLLED STUDY. Int. Res. J. Pharm. 2026;17(3):1-11. doi:10.56802/e8qzhp89